Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report)’s share price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.35 and traded as low as $1.2864. Oxbridge Re shares last traded at $1.31, with a volume of 1,785 shares.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Oxbridge Re in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $5.00.
View Our Latest Report on OXBR
Oxbridge Re Trading Down 0.8%
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last issued its earnings results on Thursday, November 6th. The insurance provider reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). The business had revenue of $0.65 million during the quarter, compared to the consensus estimate of $0.74 million. Oxbridge Re had a negative return on equity of 47.76% and a negative net margin of 109.74%.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Oxbridge Re stock. Virtu Financial LLC purchased a new position in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 17,789 shares of the insurance provider’s stock, valued at approximately $32,000. Virtu Financial LLC owned 0.23% of Oxbridge Re at the end of the most recent quarter. Institutional investors own 5.64% of the company’s stock.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Featured Stories
- Five stocks we like better than Oxbridge Re
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- Wall Street Stockpicker Names #1 Stock of 2026
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
